InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by TRENARY C RUSSELL III, Chairman & CEO. Officer active across 1 company, notably Outlook Therapeutics, Inc.. In total, 5 filings have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €106k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 21 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
19,925 shares@ US$1.060.073% mcap18.9% of flowCommon StockSEC:0001209191-22-038985:0
Ideal exit: 18 Mar 2023 (T+270)
25,000 shares@ US$1.390.11% mcap28.9% of flowCommon StockSEC:0001209191-21-068137:0
Ideal exit: 2 Sept 2022 (T+270)
25,000 shares@ US$1.390.11% mcap71.3% of flowCommon StockSEC:0001209191-21-068137
Ideal exit: 2 Sept 2022 (T+270)
10,000 shares@ US$1.400.045% mcap11.6% of flowCommon StockSEC:0001209191-21-067644:0
Ideal exit: 29 Aug 2022 (T+270)
10,000 shares@ US$1.400.045% mcap28.7% of flowCommon StockSEC:0001209191-21-067644
Ideal exit: 29 Aug 2022 (T+270)
5 of 5 declarations
About TRENARY C RUSSELL III
C. Russell Trenary III is the Chief Executive Officer of Outlook Therapeutics, Inc. He leads the company with a strategic vision, focusing on innovation and growth. His leadership is crucial in guiding the company's initiatives in the biotechnology sector.
